AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-2595801_ITM" title="Facts and information about Once-daily topical for acne. (Dermatology).">Once-daily topical for acne. (Dermatology).</a>
Close
Set up an RSS feed that alerts you when new articles from OB GYN News are available.
Frequently asked questions about RSS feeds
Once-daily topical for acne. (Dermatology).
A once-daily topical clindamycin gel is a "viable alternative" to the standard twice-daily formulation for acne treatment, with equivalent efficacy and fewer side effects.
This conclusion emerged from a multicenter, randomized, single-blind study. Study subjects included 667 patients with mild to moderate acne vulgaris, Ronald L. Rizer, Ph.D., said at the annual meeting of the American Academy of Dermatology.
Patients were randomized to one of five treatment arms: once-daily clindamycin 1% gel (Clindagel), twice-daily Clindagel, twice-daily clindamycin 1% gel ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Once-daily topical for psoriasis adds choice and convenience.(News)
- Magazine article from: Skin & Allergy News Johnson, Kate February 1, 2006 700+ words
The Food and Drug Administration in January approved Taclonex, a new topical therapy for psoriasis. The combined steroid and vitamin [D.sub.3] analogue ointment adds both choice and convenience to the currently available first-line treatments for the disease, Dr. Alan Menter said in an interview.
- New once-daily topical therapy for acne is on the horizon.(Clinical Rounds)
- Magazine article from: Pediatric News Jancin, Bruce June 1, 2008 700+ words
WAIKOLOA, HAWAII -- Food and Drug Administration marketing approval is anticipated for a novel topical acne therapy: the combination of the retinoid adapalene 0.1% and benzoyl peroxide 2.5% in a fixed-dose gel formulation applied once daily, Dr. David M. Pariser said at the annual Hawaii
- FDA approves once-daily topical combo of steroid, vitamin D for psoriasis...
- Magazine article from: Family Practice News Johnson, Kate March 1, 2006 700+ words
The Food and Drug Administration in January approved Taclonex, a new topical therapy for psoriasis. The combined steroid and vitamin D3 analogue ointment adds both choice and convenience to the currently available first-line treatments for the disease, Dr. Alan Menter said in an interview. "It's a
- Results Published for Once-Daily Topical Cream for Basal Cell Carcinoma.
- Press release article from: Business Wire October 1, 2002 700+ words
Business Editors & Health/Medical Writers ST. PAUL, MinnBUSINESS WIREOct. 1, 2002 A clinical study, published today in the Journal of American Academy of Dermatology, shows effects of Imiquimod 5% cream in the treatment of superficial basal cell carcinoma (sBCC)(1). This phase II, randomized,
- Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the...
- Magazine article from: Journal of Drugs in Dermatology Elewski, Boni Ling, Mark R. Phillips, Tania J. July 1, 2006 700+ words
Abstract Background: The first gel formulation of ketoconazole has been tested in 2-week treatment courses. Objective: To evaluate the efficacy and safety of a new, once-daily, 2-week ketoconazole 2% gel treatment in moderate to severe seborrheic dermatitis. Methods: Four hundred fifty-nine
- ISTA Pharmaceuticals Announces Phase III Results for Once-Daily Topical...
- Press release article from: PR Newswire December 4, 2008 700+ words
IRVINE, Calif., Dec. 4 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. , an ophthalmic pharmaceutical company, today announced results from the Company's recently completed Phase III clinical program of Xibrom(TM) (0.09% bromfenac sodium ophthalmic solution) QD (once-daily). The program
- Craniofacial hyperhidrosis successfully treated with topical glycopyrrolate.
- Magazine article from: Southern Medical Journal Luh, Join Y. Blackwell, Thomas A. July 1, 2002 700+ words
...especially pronounced on the forehead, nose, and upper lip. Daily topical application of a 0.5% glycopyrrolate solution to the face...reasons given for discontinuing the use of aluminum chloride. Daily topical application of a 0.5% glycopyrrolate solution to the face...
- Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005%...
- Magazine article from: Journal of Drugs in Dermatology Menter, Alan Abramovits, William Colon, Luz E. Johnson, Lori A. Gottschalk, Ronald W. January 1, 2009 700+ words
...were also excluded from the study. Patients were randomized to twice-daily topical treatment with either CP spray (doses >8 hours apart) or once daily topical treatment with C-BD ointment, in accordance with their Food and Drug...